MedPath

Feasibility & Acceptability of a Virtual Sister Circle Intervention for Black Women With Depressive Symptoms

Not Applicable
Completed
Conditions
Depressive Symptoms
Depression
Interventions
Behavioral: Sister Circle protocol
Registration Number
NCT04837573
Lead Sponsor
Kia Skrine Jeffers, PhD, RN, PHN
Brief Summary

The purpose of this study is to evaluate the feasibility and acceptability of a protocol for middle- and older-aged Black women with depressive symptoms.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
30
Inclusion Criteria
  • Identify as Black or African American
  • Identify as female
  • Age 40 years and older
  • Community-dwelling
  • Self-report of experiencing depressive symptoms
  • Ability to commit to the 8-week intervention
  • Access to Zoom
  • Speak and read English
Exclusion Criteria
  • Have a diagnosis of bipolar, but is not taking medication for the condition
  • Experiencing psychosis

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Group 2 Intervention, Weeks 9-16Sister Circle protocolDuring Weeks 9-16, Group 2 receives the Intervention and Group 1 receives no treatment.
Group 1 Intervention, Weeks 1-8Sister Circle protocolDuring Weeks 1-8, Group 1 receives the Intervention and Group 2 receives no treatment.
Primary Outcome Measures
NameTimeMethod
Assess Acceptability according to the Theoretical Framework of Acceptability16 weeks

Qualitative assessment of Acceptability. The interview guide will be organized according to the constructs of the Theoretical Framework of Acceptability. Methodological conventions of qualitative description will be used to analyze the data.

Recruitment, completion, and retention rates of participants16 weeks

80 percent recruitment, 80 percent completion, and 75 percent retention

Secondary Outcome Measures
NameTimeMethod
Changes in Acceptance and Action Questionnaire II (AAQ-II) from baseline at 8 weeks and 16 weeksbaseline, 8 weeks, 16 weeks

Exploratory description of effect sizes

Changes in Positive and Negative Affect Schedule (PANAS) Scale from baseline at 8 weeks and 16 weeksbaseline, 8 weeks, 16 weeks

Exploratory description of effect sizes

Changes in Perceived Stress Scale (PSS) from baseline at 8 weeks and 16 weeksbaseline, 8 weeks, 16 weeks

Exploratory description of effect sizes

Trial Locations

Locations (1)

University of California, Los Angeles

🇺🇸

Los Angeles, California, United States

© Copyright 2025. All Rights Reserved by MedPath